← Open Payments lookup

VERONICA ZAVALA-CARRAWAY: Open Payments

NPI 1184998197 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$715 in 36 payments from 8 companies in 2025. Trend: 2023 $331 · 2024 $64 · 2025 $715

Food & beverage: $715
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP8$233
Novo Nordisk Inc8$163
Lilly USA, LLC11$149
Amgen Inc.4$68
Merck Sharp & Dohme LLC2$39
Boehringer Ingelheim Pharmaceuticals, Inc.1$27
ABBVIE INC.1$19
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$16

Products named: FARXIGA, Rybelsus, MOUNJARO, OTEZLA, AIRSUPRA, Ozempic, LAGEVRIO, JARDIANCE.

Industry payments across TX — which companies pay providers there.